STOCK TITAN

Biote Medical Announces Appointments Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary

Biote Medical has announced the election of Dr. Mark Cone and Dana Jacoby to its Board of Directors, strengthening its leadership team with over 60 years of combined experience in healthcare and business management. Dr. Cone is the Market President of Privia Health in South Texas, while Jacoby has led nearly $1 billion in healthcare mergers and transactions. Their appointments aim to enhance Biote's growth and address hormone deficiencies affecting over 200 million Americans.

Positive
  • Dr. Cone and Jacoby bring extensive healthcare and business experience.
  • Their leadership is expected to drive growth and expansion for Biote.
Negative
  • None.

Dr. Mark Cone and Dana L. Jacoby elected to the Board of Directors for Biote Medical

IRVING, Texas--(BUSINESS WIRE)-- Biote Medical, a hormone optimization company that provides evidence-based therapeutic solutions to treat hormone imbalances in women and men, today announced the appointments of Dr. Mark Cone and Dana Jacoby to the company’s Board of Directors. Cone and Jacoby bring six decades of combined experience in healthcare practice and business leadership to the company’s Board.

Dana Jacoby (Photo: Business Wire)

Dana Jacoby (Photo: Business Wire)

“The appointments of Dr. Cone and Dana Jacoby will support Biote’s continued growth as we scale our commercial efforts to support rapid national expansion to address the over 200 million Americans suffering with hormone deficiency,” said Terry Weber, Chief Executive Officer of Biote Medical. “Biote is transforming healthy aging with precision hormone therapy optimized by a proprietary dosing algorithm. These additions to our board will provide valuable contributions to our mission, science and commercial success.”

Dr. Mark Cone brings 30 years of healthcare leadership and women’s health expertise and advocacy to Biote Medical’s Board. He is the Market President of Privia Health’s South Texas market (Nasdaq: PRVA), a national physician practice management company. He is the President of Privia Medical Group Gulf Coast, a 300-provider multi-specialty group. Cone is Vice President of the Board of Directors of the U.S. Women’s Health Alliance and Chairman of the Board of Global Women’s Health Providers, a Cedar Gate Technologies company. Prior to this Cone was the CEO of Complete MD Solutions, a physician management company, where he developed and implemented a corporate structure that maximizes practices’ autonomy and profitability. He holds a Doctor of Medicine from Baylor College of Medicine and a Bachelor of Science in biology and medicine from Texas A&M University. He currently practices Gynecology in Houston, Tx.

Dana Jacoby joins Biote Medical’s Board with more than 20 years of experience in a wide range of medical specialties, including urology, urogynecology, gastroenterology, dermatology, orthopedics, and oncology. She is Chief Executive Officer of Vector Medical Group, LLC and has consulted healthcare clients through nearly $1 billion in mergers, transactions and acquisitions. Jacoby has also held leadership roles at Specialty Networks Consulting, BSM Consulting, GE Healthcare, Allergan, and Johnson and Johnson. She holds a Master of Health Systems from the University of Medicine and Dentistry of New Jersey, a Master of Business Administration from the Wharton Fellows Program, a Master of Management from Tulane University, and a Bachelor of Science in political science and public relations from Louisiana State University.

About Biote Medical
Biote Medical is a hormone optimization company that has translated decades of scientific insight into clinically-validated medical approaches that identify and treat imbalances in the production of hormones. By partnering with medical providers across the United States, Biote Medical is educating practitioners on the scientific evidence of the roles of hormones and supplements to support improved health. We are dedicated to helping patients live better, longer by changing the way healthcare is practiced on a global level.

Media

Chelsea-Lyn Rudder

ChelseaLyn.Rudder@westwicke.com

Investor

Mike Cavanaugh

Mike.Cavanaugh@westwicke.com

Source: Biote Medical

FAQ

Who are the new board members of Biote Medical?

Dr. Mark Cone and Dana Jacoby have been elected to Biote Medical's Board of Directors.

What experience do Dr. Mark Cone and Dana Jacoby bring to Biote Medical?

They bring over 60 years of combined experience in healthcare leadership and business management.

How will the new board members impact Biote Medical?

Their appointments are expected to enhance Biote's growth and support the company's efforts to address hormone deficiencies in the U.S.

What are Biote Medical's goals with these new appointments?

Biote aims to support rapid national expansion and address hormone deficiencies affecting over 200 million Americans.

Privia Health Group, Inc.

NASDAQ:PRVA

PRVA Rankings

PRVA Latest News

PRVA Stock Data

2.45B
107.29M
10.49%
103.28%
4.71%
Health Information Services
Services-health Services
Link
United States of America
ARLINGTON